Tag: Biotechnology

Impact Newswire brings you the latest in Biotechnology news.

Syngenta and TraitSeq
Europe

Artificial intelligence is speeding up the development of the next generation of biostimulants

Syngenta Crop Protection and TraitSeq announce a pioneering collaboration which could help farmers transition to more sustainable practices. Press Release – January 09, 2025 – BASEL, Switzerland & NORWICH, England – Syngenta and the pioneering artificial intelligence (AI) company TraitSeq are combining forces to use the full power of AI for the development of innovative, high-performance biostimulants. Syngenta, a world leader in developing the next … Continue reading Artificial intelligence is speeding up the development of the next generation of biostimulants

Impact Newswire
IDRx
Untied Kingdom

GSK Enters Agreement to Acquire IDRx, Inc.

Press Release – January 13, 2025 – PLYMOUTH, Mass. – GSK plc (LSE/NYSE: GSK) and IDRx, Inc. (IDRx) today announced that they have entered into an agreement under which GSK will acquire IDRx, a Boston-based, clinical-stage biopharmaceutical company dedicated to developing precision therapeutics for the treatment of GIST. Under the agreement, GSK will pay $1 billion upfront, with potential for an additional $150 million success-based … Continue reading GSK Enters Agreement to Acquire IDRx, Inc.

Impact Newswire
BIOTECANADA
Global

BIOTECanada Welcomes New President & CEO

Press Release – January 10, 2025 – OTTAWA, Ontario – On behalf of the Board of Directors of BIOTECanada, Chairman Oliver Technow is pleased to announce the appointment of Wendy Zatylny as the incoming President & CEO of BIOTECanada, representing the biotechnology ecosystem in Canada. “Her experience in leading a national industry association equips her with valuable insights and expertise that will drive BIOTECanada’s ongoing … Continue reading BIOTECanada Welcomes New President & CEO

Impact Newswire
Enveda
United States

Enveda Welcomes Jason Kim as Chief Financial Officer

Press Release – January 10, 2025 – BOULDER, Colo. – Enveda, a biotechnology company using AI to translate life’s chemistry into new medicines, today announced the appointment of Jason Kim as Chief Financial Officer (CFO). Mr. Kim brings more than 20 years of biopharmaceutical corporate development and financial leadership experience to the Enveda team. “His proven track record of driving financial and operational success in … Continue reading Enveda Welcomes Jason Kim as Chief Financial Officer

Impact Newswire
Aro Biotherapeutics
United States

Aro Biotherapeutics Appoints Glenn Crater, MD, as Chief Medical Officer

Press Release – January 07, 2025 – PHILADELPHIA – Aro Biotherapeutics, a clinical-stage biotechnology company working to develop potent, tissue-targeted medicines, today announced the appointment of Glenn D. Crater, MD, as chief medical officer (CMO). Dr. Crater will lead the development of Aro’s pipeline of Centyrin-based, tissue-targeted medications, including the company’s lead product candidate ABX1100, a novel potential treatment for Pompe disease. “In addition, I … Continue reading Aro Biotherapeutics Appoints Glenn Crater, MD, as Chief Medical Officer

Impact Newswire